BCR and acute lymphoblastic leukemia: This is supported by the fact that a siRNA-mediated targeting of ABL/BCR strongly reduced the proliferation not only of an ALL cell line, but also of primary Ph+ PD-LTCs, which was accompanied by the induction of apoptosis.